Zilretta
Showing 1 - 17 of 17
Trochanteric Bursitis Trial in Houston (Zilretta)
Active, not recruiting
- Trochanteric Bursitis
- Zilretta
-
Houston, TexasThe University of Texas Health Science Center at Houston
Oct 4, 2022
Osteoarthritis, Knee Trial in Reno (Triamcinolone acetonide extended-release injectable suspension, Betamethasone sodium
Completed
- Osteoarthritis, Knee
- Triamcinolone acetonide extended-release injectable suspension
- Betamethasone sodium phosphate and betamethasone acetate Injectable Suspension
-
Reno, NevadaReno Orthopedic Center
Sep 17, 2021
Osteoarthritis, Knee Trial in Columbus, Lewis Center (Zilretta, Synvisc-One 48 MG in 6 ML Prefilled Syringe, Monovisc 88 MG Per
Recruiting
- Osteoarthritis, Knee
- Zilretta
- +2 more
-
Columbus, Ohio
- +1 more
Aug 5, 2022
Osteoarthritis, Knee, Meniscus Tear, Meniscus; Degeneration Trial in Cleveland (Zilretta Injectable Product or Placebo)
Enrolling by invitation
- Osteoarthritis, Knee
- +3 more
- Zilretta Injectable Product or Placebo
-
Cleveland, OhioCleveland Clinic Foundation
Jun 30, 2022
Tibial Meniscus Injuries, Tibial Meniscus Tears, Tibial Meniscus, Torn Trial in Lexington (Zilretta, Placebo)
Terminated
- Tibial Meniscus Injuries
- +3 more
- Zilretta
- Placebo
-
Lexington, KentuckyUK Healthcare at Turfland
Jul 21, 2022
Adhesive Capsulitis, Frozen Shoulder, Adhesive Capsulitis of Shoulder Trial in Charlottesville (triamcinolone acetonide
Recruiting
- Adhesive Capsulitis
- +2 more
- triamcinolone acetonide extended-release injectable suspension
-
Charlottesville, VirginiaUniversity of Virginia
Apr 5, 2021
Osteoarthritis, Knee, Knee Osteoarthritis, Knee Pain Chronic Trial in United States (Resiniferatoxin, Zilretta, Placebo)
Recruiting
- Osteoarthritis, Knee
- +2 more
- Resiniferatoxin
- +2 more
-
La Mesa, California
- +5 more
Mar 24, 2022
Osteoarthritis of the Shoulder, Adhesive Capsulitis Trial in United States (FX006, Normal Saline)
Terminated
- Osteoarthritis of the Shoulder
- Adhesive Capsulitis
- FX006
- Normal Saline
-
Birmingham, Alabama
- +26 more
Nov 1, 2021
Bilateral Knee Osteoarthritis Trial in Torrance, Rochester, Duncansville (FX006 32 mg, TAcs 40 mg)
Completed
- Bilateral Knee Osteoarthritis
- FX006 32 mg
- TAcs 40 mg
-
Torrance, California
- +2 more
Nov 20, 2019
Osteoarthritis of the Shoulder, Osteoarthritis of the Hip Trial in United States (FX006 32 mg, TAcs 40 mg)
Completed
- Osteoarthritis of the Shoulder
- Osteoarthritis of the Hip
- FX006 32 mg
- TAcs 40 mg
-
El Cajon, California
- +5 more
Nov 20, 2019
Meniscus Tear Trial in Cincinnati (AM3101, Saline Placebo)
Not yet recruiting
- Meniscus Tear
- AM3101
- Saline Placebo
-
Cincinnati, OhioUniversity of Cincinnati
Oct 12, 2022
Post-traumatic Osteoarthritis of the Knee Trial in San Antonio (FX006 32 mg, TCA IR 40 mg)
Terminated
- Post-traumatic Osteoarthritis of the Knee
- FX006 32 mg
- TCA IR 40 mg
-
San Antonio, TexasSan Antonio Military Medical Center
Aug 1, 2018
Osteoarthritis of the Knee Trial in United States (FX006 32 mg, TCA IR 40)
Completed
- Osteoarthritis of the Knee
- FX006 32 mg
- TCA IR 40
-
Canoga Park, California
- +3 more
Dec 13, 2017
Osteoarthritis of the Knee, Type 2 Diabetes Trial in United States (FX006 32 mg, TCA IR 40 mg)
Completed
- Osteoarthritis of the Knee
- Type 2 Diabetes Mellitus
- FX006 32 mg
- TCA IR 40 mg
-
Anaheim, California
- +7 more
Dec 27, 2017
Osteoarthritis of the Knee Trial in Canada, United States (FX006 32 mg, Placebo, FX006 16 mg)
Completed
- Osteoarthritis of the Knee
- FX006 32 mg
- +2 more
-
Anniston, Alabama
- +43 more
Mar 19, 2018